Media: Announcements | 26 February 2021
Want to share your news with your industry? Submit a press release.
Top 1000 Companies Ranked by Revenue – in Multiple Sectors & Countries.
Global law firm Hogan Lovells has added Anna Weinstein as a Senior Director in its Government Relations and Public Affairs practice based in Washington, D.C. She is a seasoned health care strategist and recognized political adviser with 20 years of legislative and regulatory experience. Anna helps clients in the health and life sciences arenas navigate the process of developing and shaping complex federal legislation and regulatory policy. She also advises clients on formulating and implementing approaches to achieve objectives by building stakeholder coalitions and mobilizing grassroots efforts.
Before joining Chamber Hill Strategies, Anna was a principal at a boutique health care policy/advocacy firm. Before that, she headed the health care practice at the Podesta Group, a top government relations and public affairs firm. At both she represented a variety of pharmaceutical, post-acute care, health information technology, medical device companies and provider associations. Prior to that, she was the lead Democratic lobbyist for the Biotechnology Innovation Organization, a trade association representing over 1,100 members, where she focused on health care, intellectual property and biodefense issues. Anna also worked at another prominent international law firm as a senior health care adviser, where she focused on payment and regulatory policy affecting physicians, dialysis providers, biopharmaceutical and device manufacturers, ambulatory surgery centers and clinical laboratories.
At the corporate level, Anna has experience designing and executing federal and state advocacy agendas related to fiscal and regulatory policy for a leading U.S. provider of home oxygen and sleep therapy services, equipment and respiratory medications. She also directed federal policy and congressional relations on behalf of the major global producers of plasma-based and recombinant biological therapeutics at the Plasma Protein Therapeutics Association.
Anna began her career as a research assistant at the Harvard School of Public Health and Kennedy School of Government and following graduate school she was a special advisor to the CEO of AcademyHealth. She also worked in the Executive Office of the President within the Clinton administration, where she served as an aide to the deputy assistant to the president for health policy development.
Anna earned a Bachelor of Arts in history with a minor in Italian literature and culture from Middlebury College, as well as a Master of Public Policy with a concentration in health care economics from Georgetown University.